Top Markets
#1 City Boy City Boy +19.56%
#2 pippin pippin +18.79%
#3 TRIA TRIA +16.20%
#4 Osaka Protocol Osaka Protocol +14.57%
#5 River Pts River Pts +13.00%
#6 Aria.AI Aria.AI +12.75%
#7 Janction Janction +11.53%
#8 Infinity Ground Infinity Ground +11.29%
#9 Strategic Oil Supply Strategic Oil Supply +10.67%
#10 Orochi Network Orochi Network +9.45%
Coin of the day
City Boy City Boy
Настройки
Язык
Pусский
Валюта
USD
Тема
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Ранг среди акций #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Цена акции
$37.45
Рыночная капитализация
$166.43B
Изменение (1 день)
-2.55%
Изменение (1 год)
-53.09%
Страна
DK
Торговля Novo Nordisk A/S (NVO)

Категория

Healthcare
Коэффициент P/S для Novo Nordisk A/S (NVO)
Коэффициент P/S на January 2026 TTM: 5.21
Согласно последним финансовым отчетам и цене акций Novo Nordisk A/S, текущий коэффициент P/S (TTM) составляет 5.21. В конце 2026 он составлял 0.
История P/S для Novo Nordisk A/S с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.90 89.90%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.40 3.60%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.14 17.70%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -41.63%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.90 147.31%
NL